This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A new study from an industry advocacy group in California examines the content of dozens of unregulated intoxicating “hemp” products that are easily available in the Golden State despite being banned by state law. However, the following year the DEA put off its decision pending further public commentary. percent THC.
But there’s a group of players who’ve been surprisingly quiet, despite potentially having the most to gain: DEA-registered bulk marijuana manufacturers. However, under current US law, DEA Registrants are missing out on a massive opportunity. tons in Q4 of 2024 a fourfold increase from Q1. billion by 2027.
For immediate release: Media Briefing on the Next Steps of the Rescheduling Process July 22, 2024, 1 pm ET Zoom Conference: Please go to the bottom of this page for the Zoom sign-in link.
Happy 2024 – let’s start the year off with a shout-out to Colorado, where the retail market is celebrating an anniversary. The DEA is conducting a review of cannabis scheduling. As of January 2024, 24 states have legalized adult-use cannabis; over half the US population lives in a state where it is legal.
The laws surrounding these products have some stipulations. The Drug Enforcement Administration (DEA) is working on amending the Farm Bill in 2024 to create new rules and regulations regarding synthetic weed. Since hemp products must contain less than 0.3%
DE-SCHEDULING As we’re reported before (most recently here ), the Department of Health and Human Services (HHS) has recommended that the Drug Enforcement Administration (DEA) move cannabis from Schedule I to Schedule III. Now, some Senate Democrats are advocating that the DEA de-schedule cannabis altogether.
Whether you’re planning a long road trip or flying to see family over the holidays — the following will ensure you stay on the right side of the law. >> Learn more: Where is Cannabis Legal? Breaking the law here, even with only small amounts of cannabis, will result in misdemeanor charges. Possession of up to 1.5
Ohio legislators are busy writing a marijuana law. The DEA sends a letter to Georgia pharmacies. Well, apparently the Drug Enforcement Administration (DEA) noted that as well, and they didn’t take kindly to it. Pharmacies received a letter from the agency recently telling them the practice is a violation of federal law.
In a letter to the Democratic governor written by Good last week, the representative for Virginia’s 5th Congressional District exhorted Northam not to sign the legalization bill, HB 2312, into law. As recent as 2016, the DEA has reviewed and determined that under its judgment marijuana should remain a Schedule I substance.”.
Cannabis retail sales can be outlawed by local jurisdictions through the enactment of zoning laws. With a recreational cannabis market geared up for launch on January 1, 2024, Virginians have a lot to look forward to. In fact, this year looks set to be one of the most successful years for cannabis reform in the United States so far. .
It was called the “Cuban cigar of the marijuana world” by a DEA agent in 1967 and even compared with French wine. Healthcare expenditure estimated by 2024. Estimated Prevalence of cannabis users by 2024. It was a quite lucrative business, with a kilo worth 3$ at the farm easily sold for 4000$ in the U.S. in the 1970. Population.
The 2019 edition of the Hemp and CBD Industry Factbook released figures that show retail sales of CBD topping $1 billion this year, and predicted that number could hit $10 billion by 2024. The governor says the legislature is trying to veto executive regulations; the legislators say they will remove the provision from the law.
The Governor allowed the bill to become law without his signature. As of now, this is still a proposal, and it’s anyone’s guess if the DEA (who would do the actual re-scheduling) will think that’s a good idea. Watch for updates on this story in 2024. Delaware legalized adult-use after many, many failed attempts.
Being categorized as Schedule I means these drugs have no accepted medical use, are considered at elevated risk for abuse, and, with limited exceptions (like an approved clinical trial as discussed below), are illegal to possess, sell, or consume under federal law. Non-Commercial Operations. Underground Therapists. View source.].
Navigating local, state, and federal regulations Although state-licensed cannabis labs are legal under state law, the federal government sees them in violation of federal law. However, this may change with rescheduling that is going to be revisited on Dec 2, 2024.
The Drug Enforcement Administration (DEA) seems happy to respond to public and private parties inquiring about the control status of various substances. DEA answers some of these inquiries more quickly than others, and the response letters are usually short and to the point. What are the legal ramifications of DEA writing these things?”
The Drug Enforcement Administration (DEA) seems happy to respond to public and private parties inquiring about the control status of various substances. DEA answers some of these inquiries more quickly than others, and the response letters are usually short and to the point. What are the legal ramifications of DEA writing these things?”
cannabis community awaits the resumption of the DEA’s administrative law hearing on rescheduling marijuana later this month, this blog will take a glimpse at the ever-dynamic global landscape of cannabis policy. Key global cannabis law developments in 2024 Germany passed a quasi-legalization law with two phases.
In a much anticipated announcement, the Drug Enforcement Administration (DEA) issued a notice of proposed rulemaking to reschedule marijuana, from Controlled Substances Act (CSA) schedule I to schedule III (the “Proposed Rule”). First , DEA is not proposing an interim final rule. 11, 2024) (“OLC Op.”).1 Levine, M.D.,
In case you haven’t heard, the Drug Enforcement Administration (DEA) wants to hear from you on marijuana rescheduling. Specifically, DEA invites your comments on its notice of proposed rulemaking (NPRM) to move both marijuana and marijuana extract from schedule I to schedule III of the federal Controlled Substances Act (CSA).
The hemp industry is not the only one that’s pushing back against the Drug Enforcement Administration (DEA)’s hemp Interim Final Rule (the “ Rule ”). If you read this blog, you’ll recall the hemp industry sued the DEA following the release of its Rule in August 2020. billion by 2024, increasing from $1.2 billion in 2019.
The hemp industry is not the only one that’s pushing back against the Drug Enforcement Administration (DEA)’s hemp Interim Final Rule (the “ Rule ”). If you read this blog, you’ll recall the hemp industry sued the DEA following the release of its Rule in August 2020. billion by 2024, increasing from $1.2 billion in 2019.
“THCA flower is legal under federal law” Maybe. Griffen’s article is just one of many parsing the language of the 2018 Farm Bill and a 2023 DEA letter on the topic. See also: “ THCA and the DEA: Rod Breaks Down the Latest News ” from Rod Kight, an another attorney prominent in the space. And DEA often loses in court.
I, as well as another colleague here at the firm, tend to think on balance that these products are not permitted under current federal law. But, it bears mentioning that DEA’s interpretations are just that. And here, I tend to think that federal courts would side with DEA. This last point is extremely vague.
They’re calling it the Rural Prosperity and Food Security Act of 2024 (the “Senate bill”). The Senate bill follows on the House’s proposal, called the Farm, Food and National Security Act of 2024 (the “House bill”), offered in May. That could happen in 2024, but seems more likely in 2025 when the new Congress convenes.
Ability to source marijuana genetic material from outside Colorado Senate Bill 23-271 , which went into effect in early 2024, aims to enhance Colorados marijuana industry. This law significantly expands sourcing options for Colorado cultivators, including opportunities, both domestic and international. Thats where we come in.
Minnesota hemp edible law challenges the 2 medical license holders: [link]. Virginia 2024 adult use program may be postponed: [link]. Massachusetts has new cannabis law: [link]. Time on Right to Try laws: [link]. DEA grants research license for psychedelics and major depression first human trial: [link].
According to the Pew Research Center (2024), 88% of Americans believe cannabis should be legal for either medical or recreational use. If Congress would like to change the legal status of marijuana, they would do so before or after the DEA makes a final scheduling decision. Under the federal U.S.
Diamondback Investment Group, LLC , handed the DEA a big loss when it comes to hemp – at least for now. In Anderson , the court held that DEA’s interpretation that a host of hemp-derived products were illegal was essentially wrong. Raimondo , a 2024 US Supreme Court decision. delta-9 THC. THC, it is legal.
In no particular order, I’ll address a few reasons why the back half of 2024 will be a bad stretch for intoxicating hemp products. Raimondo , a 2024 US Supreme Court decision. That’s because the DEA routinely issues what amount to opinion letters as to whether this or that cannabinoid is or is not a schedule I narcotic.
Yesterday, the Drug Enforcement Administration (DEA) near-noticed a hearing for its marijuana rescheduling proposal. The hearing would begin on December 2, 2024 at 9 a.m. Back in March, when DEA agreed to initiate rulemaking to reschedule marijuana, I wrote that “I doubt cannabis will be on Schedule III by November.”
At least not in Congress, and at least not before the 2024 general election. Federal law currently classifies marijuana in Schedule I of the Controlled Substances Act, the classification meant for the most dangerous substances. No state’s regulatory program will comply with federal laws if cannabis is on any CSA schedule.
The DEA still classifies cannabis as a Schedule I controlled substance, a designation reserved for drugs with no medical value and a high potential for abuse. The governor of New Mexico signed a legalization bill into law in 2021, and residents can now grow and possess cannabis, but it will not be available for retail sale until 2022.
While many people want recreational weed legalized simply so they have easier access to it, passing this law would open up economic opportunities, expunge criminal records, and create jobs for people of color who have been historically disenfranchised by cannabis criminalization. It is scheduled at the same level as heroin.”
That’s not because a particular investment may not be sound, rather because federal law creates inherent conflicts between immigration eligibility and participating in a cannabis venture. Immigration law is contained in the Immigration and Nationality Act (“INA”). The INA is federal law and administered by the U.S.
A transition into a Schedule III would mean that cannabis would then be defined as having moderate potential for abuse but with accepted medical use within federal law. They must work closely with the Drug Enforcement Administration (DEA) to pass the move. Looking Ahead — Whats To Come?
In each presidential election cycle, the Canna Law Blog runs a classy series of posts grading the candidates as to their positions on cannabis. Last time around, we (one of our law clerks) gave him a “D.” What DEA ends up doing here is far from certain , and things seem to be moving pretty slowly. Hunter’s dad).
Marijuana rescheduling is mired in an administrative rulemaking process, whereby the Drug Enforcement Administration (DEA) is the hapless, cynical proponent of a proposed Department of Justice (DOJ) rule. Midway through the rulemaking process, DEA Chief Administrative Law Judge John J. Lets call them the Villagers.)
In May 2024, the U.S. THC content) under federal law, signaling a major shift in the U.S. However, the rescheduling process is yet to be finalized, and although some optimistic advocates expected the decision to be fast-tracked before the November 2024 election, the fight for cannabis reform will not be won so quickly.
Earlier this year, the DEA initiated rulemaking to reclassify cannabis as a schedule III narcotic. This is probably the biggest news in cannabis reform since the Controlled Substances Act became law. A lot of folks had hoped that cannabis would be rescheduled in advance of the 2024 election.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content